Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #82504 on Elite Pharmaceuticals Inc (ELTP)
Couch
12/31/13 4:22 PM
#82507 RE: dr_lowenstein #82504
“The start of the ELI-201 pilot study marks a major milestone for the development of products utilizing our proprietary abuse deterrent technology,” said Nasrat Hakim, Elite’s President and CEO. “I am extremely pleased with the progress Elite has made with the development of this technology. We have set several initiatives in motion and all of our research and development projects are on or ahead of schedule. We appreciate the guidance and expertise that has been provided by Camargo and look forward to this next phase for the Company.”